BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8395700)

  • 1. Retroperitoneal lymphadenectomy remains the treatment of choice in nonseminomatous germ cell tumors.
    Graham SD
    Semin Urol; 1993 May; 11(2):85-91. PubMed ID: 8395700
    [No Abstract]   [Full Text] [Related]  

  • 2. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.
    Spiess PE; Brown GA; Liu P; Tu SM; Tannir NM; Evans JG; Kamat AM; Kassouf W; Pisters LL
    J Urol; 2007 Jan; 177(1):131-8. PubMed ID: 17162023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance versus nerve-sparing retroperitoneal lymphadenectomy in stage I nonseminomatous germ-cell tumors.
    Lowe BA
    Urol Clin North Am; 1993 Feb; 20(1):75-83. PubMed ID: 8381999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of early-stage nonseminomatous germ cell tumors of the testis.
    Lieskovsky G; Weinberg AC; Skinner DG
    Semin Urol; 1984 Nov; 2(4):208-16. PubMed ID: 6095395
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant chemotherapy for stage II nonseminomatous germ cell tumors.
    Kondagunta GV; Motzer RJ
    Urol Clin North Am; 2007 May; 34(2):179-85; abstract ix. PubMed ID: 17484923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
    Yoon GH; Stein JP; Skinner DG
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):75-85. PubMed ID: 15757440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retroperitoneal lymphadenectomy in testicular tumors].
    Mast GJ; Jung P; Moll V; Neisius D
    Chirurg; 1989 Mar; 60(3):148-52. PubMed ID: 2541979
    [No Abstract]   [Full Text] [Related]  

  • 9. Overview: treatment of local regional disease.
    Donohue JP
    Prog Clin Biol Res; 1990; 350():283-93. PubMed ID: 2166958
    [No Abstract]   [Full Text] [Related]  

  • 10. Reoperative retroperitoneal lymph node dissection for metastatic germ cell tumors: analysis of local recurrence and predictors of survival.
    Pedrosa JA; Masterson TA; Rice KR; Bihrle R; Beck SD; Foster RS
    J Urol; 2014 Jun; 191(6):1777-82. PubMed ID: 24518787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and therapeutic significance of retroperitoneal lymph node dissection in low stage and localized disease: point of view.
    Whitmore WF
    Prog Clin Biol Res; 1985; 203():263-8. PubMed ID: 3008179
    [No Abstract]   [Full Text] [Related]  

  • 12. Retroperitoneal lymph node dissection in testicular cancer.
    Jacobsen NE; Foster RS; Donohue JP
    Surg Oncol Clin N Am; 2007 Jan; 16(1):199-220. PubMed ID: 17336244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study.
    Sun M; Abdollah F; BudaĆ¼s L; Liberman D; Tian Z; Morgan M; Johal R; Schmitges J; Shariat SF; Montorsi F; Greafen M; Perrotte P; Karakiewicz PI
    Ann Surg Oncol; 2011 Oct; 18(10):2997-3004. PubMed ID: 21509630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
    J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
    Beck SD; Foster RS; Bihrle R; Donohue JP
    Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Fornara P; Hoda MR
    Eur Urol; 2008 Nov; 54(5):1015-6. PubMed ID: 18722706
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Pizzocaro G
    Eur Urol; 2008 Nov; 54(5):1017-8. PubMed ID: 18722705
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Albers P
    Eur Urol; 2008 Nov; 54(5):1016-7. PubMed ID: 18722703
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Mottet N
    Eur Urol; 2008 Nov; 54(5):1018-9. PubMed ID: 18722702
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer.
    Williams SB; Steele GS; Richie JP
    J Urol; 2009 Dec; 182(6):2716-20. PubMed ID: 19836777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.